These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 28912067)
1. Farnesoid X receptor regulates SULT1E1 expression through inhibition of PGC1α binding to HNF4α. Wang S; Yuan X; Lu D; Guo L; Wu B Biochem Pharmacol; 2017 Dec; 145():202-209. PubMed ID: 28912067 [TBL] [Abstract][Full Text] [Related]
2. Cholestasis-induced bile acid elevates estrogen level via farnesoid X receptor-mediated suppression of the estrogen sulfotransferase SULT1E1. Liu X; Xue R; Yang C; Gu J; Chen S; Zhang S J Biol Chem; 2018 Aug; 293(33):12759-12769. PubMed ID: 29929982 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of CYP2C9, CYP1A1, and CYP1A2 by hepatocyte nuclear factor 4alpha requires coactivators peroxisomal proliferator activated receptor-gamma coactivator 1alpha and steroid receptor coactivator 1. Martínez-Jiménez CP; Castell JV; Gómez-Lechón MJ; Jover R Mol Pharmacol; 2006 Nov; 70(5):1681-92. PubMed ID: 16882880 [TBL] [Abstract][Full Text] [Related]
4. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β. Noh K; Kim YM; Kim YW; Kim SG Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890 [TBL] [Abstract][Full Text] [Related]
5. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753 [TBL] [Abstract][Full Text] [Related]
6. RORα phosphorylation by casein kinase 1α as glucose signal to regulate estrogen sulfation in human liver cells. Hu H; Negishi M Biochem J; 2020 Sep; 477(18):3583-3598. PubMed ID: 32686824 [TBL] [Abstract][Full Text] [Related]
7. Farnesoid X receptor represses human sulfotransferase 1A3 expression through direct binding to the promoter. Dou Y; Pei S; Li Y; Wang M; Liu Z; Li J; Cao J; Qin J; Zhang M; Hou L; Sun H Chem Biol Drug Des; 2023 Nov; 102(5):1014-1023. PubMed ID: 37487659 [TBL] [Abstract][Full Text] [Related]
8. Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase. Miyata M; Matsuda Y; Tsuchiya H; Kitada H; Akase T; Shimada M; Nagata K; Gonzalez FJ; Yamazoe Y Drug Metab Pharmacokinet; 2006 Aug; 21(4):315-23. PubMed ID: 16946559 [TBL] [Abstract][Full Text] [Related]
9. Hepatocyte nuclear factor 4 alpha and farnesoid X receptor co-regulates gene transcription in mouse livers on a genome-wide scale. Thomas AM; Hart SN; Li G; Lu H; Fang Y; Fang J; Zhong XB; Guo GL Pharm Res; 2013 Sep; 30(9):2188-98. PubMed ID: 23462932 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-561 promotes acetaminophen-induced hepatotoxicity in HepG2 cells and primary human hepatocytes through downregulation of the nuclear receptor corepressor dosage-sensitive sex-reversal adrenal hypoplasia congenital critical region on the X chromosome, gene 1 (DAX-1). Li M; Yang Y; He ZX; Zhou ZW; Yang T; Guo P; Zhang X; Zhou SF Drug Metab Dispos; 2014 Jan; 42(1):44-61. PubMed ID: 24104199 [TBL] [Abstract][Full Text] [Related]
13. PGC1α regulates ACMSD expression through cooperation with HNF4α. Koshiguchi M; Hirai S; Egashira Y Amino Acids; 2018 Dec; 50(12):1769-1773. PubMed ID: 30232574 [TBL] [Abstract][Full Text] [Related]
14. Two novel cis-elements involved in hepatocyte nuclear factor 4α regulation of acyl-coenzyme A:cholesterol acyltransferase 2 expression. Zhang Z; Liu J; Xi Y; Yang R; Chen H; Li Z; Liu D; Liang C Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):162-71. PubMed ID: 22155889 [TBL] [Abstract][Full Text] [Related]
15. Transcriptional Regulation of Human UDP-Glucuronosyltransferase 2B10 by Farnesoid X Receptor in Human Hepatoma HepG2 Cells. Lu D; Wang S; Xie Q; Guo L; Wu B Mol Pharm; 2017 Sep; 14(9):2899-2907. PubMed ID: 28267333 [TBL] [Abstract][Full Text] [Related]
16. Hepatocyte nuclear factor (HNF) 4α transactivation of cytochrome P450 (Cyp) 2d40 promoter is enhanced during pregnancy in mice. Ning M; Koh KH; Pan X; Jeong H Biochem Pharmacol; 2015 Mar; 94(1):46-52. PubMed ID: 25598084 [TBL] [Abstract][Full Text] [Related]
17. FXR activation alleviates tacrolimus-induced post-transplant diabetes mellitus by regulating renal gluconeogenesis and glucose uptake. Li L; Zhao H; Chen B; Fan Z; Li N; Yue J; Ye Q J Transl Med; 2019 Dec; 17(1):418. PubMed ID: 31836014 [TBL] [Abstract][Full Text] [Related]
18. Activation of farnesoid X receptor promotes triglycerides lowering by suppressing phospholipase A2 G12B expression. Liu Q; Yang M; Fu X; Liu R; Sun C; Pan H; Wong CW; Guan M Mol Cell Endocrinol; 2016 Nov; 436():93-101. PubMed ID: 27471003 [TBL] [Abstract][Full Text] [Related]
19. Atorvastatin Induces FXR and CYP7A1 Activation as a Result of the Sequential Action of PPARγ/PGC-1α/HNF-4α in Hep3B Cells. Lee J; Hong EM; Jung JH; Park SW; Lee SP; Koh DH; Jang HJ; Kae SH Korean J Gastroenterol; 2021 Mar; 77(3):123-131. PubMed ID: 33686046 [TBL] [Abstract][Full Text] [Related]
20. HS218 as an FXR antagonist suppresses gluconeogenesis by inhibiting FXR binding to PGC-1α promoter. Xu X; Shi X; Chen Y; Zhou T; Wang J; Xu X; Chen L; Hu L; Shen X Metabolism; 2018 Aug; 85():126-138. PubMed ID: 29577938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]